Skip to main content

Neurodevelopmental Disorders

1
Pipeline Programs
6
Companies
6
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

IAMA Therapeutics
IAMA TherapeuticsItaly - Genoa
1 program
1
IAMA-6Phase 11 trial
Active Trials
NCT06300398Completed72Est. Nov 2024
Young BioPharma
Young BioPharmaMA - Lowell
2 programs
Focused Acceptance and Commitment TherapyN/A1 trial
Focused Acceptance and Commitment TherapyN/A1 trial
Active Trials
NCT05584059Recruiting150Est. Dec 2025
NCT05803252Completed104Est. Feb 2026
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
DanceN/A1 trial
Active Trials
NCT04762290Completed35Est. Aug 2024
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Family networks programN/A1 trial
Active Trials
NCT02792894Completed540Est. Apr 2018
Eppendorf
EppendorfGermany - Hamburg
1 program
Longitudinal Study of Neurogenetic DisordersN/A1 trial
Active Trials
NCT03492060Recruiting1,000Est. Dec 2030

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
IAMA TherapeuticsIAMA-6
Young BioPharmaFocused Acceptance and Commitment Therapy
Young BioPharmaFocused Acceptance and Commitment Therapy
Angeles TherapeuticsDance
EppendorfLongitudinal Study of Neurogenetic Disorders
Human BioSciencesFamily networks program

Clinical Trials (6)

Total enrollment: 1,901 patients across 6 trials

NCT06300398IAMA TherapeuticsIAMA-6

IAMA-6 Oral Dose Study in Healthy Adults

Start: Jan 2024Est. completion: Nov 202472 patients
Phase 1Completed
NCT05803252Young BioPharmaFocused Acceptance and Commitment Therapy

Videoconferencing-based Focused Acceptance and Commitment Therapy for Parents of SHCN Children

Start: Mar 2023Est. completion: Feb 2026104 patients
N/ACompleted
NCT05584059Young BioPharmaFocused Acceptance and Commitment Therapy

Pai.ACT Programme for Parents of Children With Special Healthcare Needs - Phase I

Start: Dec 2022Est. completion: Dec 2025150 patients
N/ARecruiting
NCT04762290Angeles TherapeuticsDance

Dance for Children With Autism

Start: Jan 2021Est. completion: Aug 202435 patients
N/ACompleted
NCT03492060EppendorfLongitudinal Study of Neurogenetic Disorders

Longitudinal Study of Neurogenetic Disorders

Start: Jun 2018Est. completion: Dec 20301,000 patients
N/ARecruiting
NCT02792894Human BioSciencesFamily networks program

Family Networks (FaNs) for Children With Developmental Disorders and Delays

Start: Apr 2016Est. completion: Apr 2018540 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 1,901 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.